128 related articles for article (PubMed ID: 26308138)
1. Aggressive MLL gene rearranged CD7+ CD56+ myeloid / natural killer cell precursor acute leukaemia with extramedullary relapse in the uterus and breast.
Soon G; Lee SY; Wang S
Pathology; 2015 Oct; 47(6):588-91. PubMed ID: 26308138
[No Abstract] [Full Text] [Related]
2. Monitoring mixed lineage leukemia expression may help identify patients with mixed lineage leukemia--rearranged acute leukemia who are at high risk of relapse after allogeneic hematopoietic stem cell transplantation.
Liu J; Wang Y; Xu LP; Liu DH; Qin YZ; Chang YJ; Liu KY; Huang XJ
Biol Blood Marrow Transplant; 2014 Jul; 20(7):929-36. PubMed ID: 24631740
[TBL] [Abstract][Full Text] [Related]
3. MLL-rearranged mixed phenotype acute leukemia masquerading as B-cell ALL.
Yang W; Tran P; Khan Z; Rezk S; O'Brien S
Leuk Lymphoma; 2017 Jun; 58(6):1498-1501. PubMed ID: 27774846
[No Abstract] [Full Text] [Related]
4. Extramedullary relapse of
Aldoss I; Song JY
Blood; 2018 May; 131(22):2507. PubMed ID: 29853461
[No Abstract] [Full Text] [Related]
5. Blinatumomab for paediatric mixed phenotype acute leukaemia.
Bartram J; Balasch-Carulla M; Bhojaraja S; Adams S; Cheng D; Inglott S; Kulkarni N; Mahendrayogam A; O'Connor O; Pavasovic V; Vora A
Br J Haematol; 2021 Oct; 195(2):289-292. PubMed ID: 34254287
[No Abstract] [Full Text] [Related]
6. Infantile mixed phenotype acute leukemia (bilineal and biphenotypic) with t(10;11)(p12;q23);MLL-MLLT10.
Lou Z; Zhang CC; Tirado CA; Slone T; Zheng J; Zaremba CM; Oliver D; Chen W
Leuk Res; 2010 Aug; 34(8):1107-9. PubMed ID: 20299091
[TBL] [Abstract][Full Text] [Related]
7. Extramedullary presentation of acute leukaemia: a case of myeloid/natural killer cell precursor leukaemia.
Chen VM; McIlroy K; Loui JP; Fay K; Ward C
Pathology; 2003 Aug; 35(4):325-9. PubMed ID: 12959763
[TBL] [Abstract][Full Text] [Related]
8. Relapsed infant MLL-rearranged acute lymphoblastic leukemia with additional genetic alterations.
Ishida H; Kanamitsu K; Washio K; Muraoka M; Sakakibara K; Matsubara T; Kanzaki H; Shimada A
Pediatr Blood Cancer; 2016 Nov; 63(11):2059-60. PubMed ID: 27322816
[No Abstract] [Full Text] [Related]
9. TanCAR T cells targeting CD19 and CD133 efficiently eliminate MLL leukemic cells.
Li D; Hu Y; Jin Z; Zhai Y; Tan Y; Sun Y; Zhu S; Zhao C; Chen B; Zhu J; Chen Z; Chen S; Li J; Liu H
Leukemia; 2018 Sep; 32(9):2012-2016. PubMed ID: 30046161
[No Abstract] [Full Text] [Related]
10. Chimeric antigen receptor T-cell therapy for marrow and extramedullary relapse of infant acute lymphoblastic leukemia.
Moskop A; Pommert L; Thakrar P; Talano J; Phelan R
Pediatr Blood Cancer; 2021 Jan; 68(1):e28739. PubMed ID: 33009894
[TBL] [Abstract][Full Text] [Related]
11. Multiparameter flow cytometry applications in the diagnosis of mixed phenotype acute leukemia.
Porwit A; Béné MC
Cytometry B Clin Cytom; 2019 May; 96(3):183-194. PubMed ID: 31033213
[TBL] [Abstract][Full Text] [Related]
12. Mixed lineage rearranged leukaemia: pathogenesis and targeting DOT1L.
Stein EM; Tallman MS
Curr Opin Hematol; 2015 Mar; 22(2):92-6. PubMed ID: 25635757
[TBL] [Abstract][Full Text] [Related]
13. MLL-ENL-mediated leukemia initiation at the interface of lymphoid commitment.
Ugale A; Säwén P; Dudenhöffer-Pfeifer M; Wahlestedt M; Norddahl GL; Bryder D
Oncogene; 2017 Jun; 36(22):3207-3212. PubMed ID: 28068328
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-106b~25 cluster is upregulated in relapsed MLL-rearranged pediatric acute myeloid leukemia.
Verboon LJ; Obulkasim A; de Rooij JD; Katsman-Kuipers JE; Sonneveld E; Baruchel A; Trka J; Reinhardt D; Pieters R; Cloos J; Kaspers GJ; Klusmann JH; Zwaan CM; Fornerod M; van den Heuvel-Eibrink MM
Oncotarget; 2016 Jul; 7(30):48412-48422. PubMed ID: 27351222
[TBL] [Abstract][Full Text] [Related]
15. Acute T-lymphoblastic leukemia relapsed with the character of myeloid/natural killer cell precursor phenotype: a case report.
Hashimoto S; Toba K; Aoki S; Tsuchiyama J; Tsukada N; Takahashi H; Takahashi M; Aizawa Y
Leuk Res; 2002 Feb; 26(2):215-9. PubMed ID: 11755472
[TBL] [Abstract][Full Text] [Related]
16. Identification of a novel KMT2A/GIMAP8 gene fusion in a pediatric patient with acute undifferentiated leukemia.
Berg HE; Blackburn PR; Baughn LB; Ketterling RP; Xu X; Greipp PT; Hoppman NL; Smadbeck JB; Vasmatzis G; Shi M; Reichard KK; Viswanatha DS; Jevremovic D; Maher GM; Peterson JF
Genes Chromosomes Cancer; 2021 Feb; 60(2):108-111. PubMed ID: 33078871
[TBL] [Abstract][Full Text] [Related]
17. The potential of clofarabine in MLL-rearranged infant acute lymphoblastic leukaemia.
Stumpel DJ; Schneider P; Pieters R; Stam RW
Eur J Cancer; 2015 Sep; 51(14):2008-21. PubMed ID: 26188848
[TBL] [Abstract][Full Text] [Related]
18. Outcome of recurrent or refractory acute lymphoblastic leukemia in infants with MLL gene rearrangements: A report from the Japan Infant Leukemia Study Group.
Tomizawa D; Koh K; Hirayama M; Miyamura T; Hatanaka M; Saikawa Y; Ishii E
Pediatr Blood Cancer; 2009 Jul; 52(7):808-13. PubMed ID: 19229974
[TBL] [Abstract][Full Text] [Related]
19. [Molecular mechanisms of leukemogenesis in MLL-leukemias].
Yokoyama A
Rinsho Ketsueki; 2011 Aug; 52(8):679-85. PubMed ID: 21897075
[No Abstract] [Full Text] [Related]
20. NG2 antigen is expressed in CD34+ HPCs and plasmacytoid dendritic cell precursors: is NG2 expression in leukemia dependent on the target cell where leukemogenesis is triggered?
Bueno C; Montes R; Martín L; Prat I; Hernandez MC; Orfao A; Menendez P
Leukemia; 2008 Aug; 22(8):1475-8. PubMed ID: 18698324
[No Abstract] [Full Text] [Related]
[Next] [New Search]
